Report Detail

Medical Industry Global Fecal Pancreatic Elastase Testing Market Insights, Forecast to 2028

  • RnM4426728
  • |
  • 26 April, 2022
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Medical Industry

Summary:

Market Analysis and Insights: Global Fecal Pancreatic Elastase Testing Market
Fecal pancreatic elastase testing is a kind of test that measures the amount of elastase in the stool. The demand for fecal pancreatic elastase testing is increasing globally due to rising prevalence of exocrine pancreatic insufficiency (EPI).
The global Fecal Pancreatic Elastase Testing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Fecal Pancreatic Elastase ELISA Kits accounting for % of the Fecal Pancreatic Elastase Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Fecal Pancreatic Elastase Testing market size is valued at US$ million in 2021, while the North America and Europe Fecal Pancreatic Elastase Testing are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Fecal Pancreatic Elastase Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Fecal Pancreatic Elastase Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Fecal Pancreatic Elastase Testing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Fecal Pancreatic Elastase Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Fecal Pancreatic Elastase Testing market.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the Fecal Pancreatic Elastase Testing market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
Fecal Pancreatic Elastase Testing Breakdown Data by Type
Fecal Pancreatic Elastase ELISA Kits
Rapid Fecal Pancreatic Elastase Kits
Fecal Pancreatic Elastase Testing Breakdown Data by Application
Hospitals
Diagnostics Laboratories
Specialty Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
Labcorp
DiaSorin
ScheBo Biotech AG
Immundiagnostik AG
Invivo Healthcare
DRG Instruments GMBH
Verisana Laboratories
BÜHLMANN Laboratories AG
CerTest Biotec
R-Biopharm AG
Vitassay Healthcare
Frequently Asked Questions
What factors will challenge the Fecal Pancreatic Elastase Testing market growth?
Which end-use segment will expand at the fastest CAGR in the Fecal Pancreatic Elastase Testing market?
Which are the emerging players in the Fecal Pancreatic Elastase Testing market?
How concentrated is the Fecal Pancreatic Elastase Testing market?
Which factors are positively contributing to the Fecal Pancreatic Elastase Testing market growth?
Which are the novel product innovations in the Fecal Pancreatic Elastase Testing market?
Which product segment will emerge as the most lucrative in the Fecal Pancreatic Elastase Testing market?
Which factors are increasing the competition in the Fecal Pancreatic Elastase Testing market?
Which are the strategic measures taken by the Fecal Pancreatic Elastase Testing industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Fecal Pancreatic Elastase Testing market in the coming years?


Table of Contents

    1 Report Business Overview

    • 1.1 Study Scope
    • 1.2 Market Analysis by Type
      • 1.2.1 Global Fecal Pancreatic Elastase Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
      • 1.2.2 Fecal Pancreatic Elastase ELISA Kits
      • 1.2.3 Rapid Fecal Pancreatic Elastase Kits
    • 1.3 Market by Application
      • 1.3.1 Global Fecal Pancreatic Elastase Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
      • 1.3.2 Hospitals
      • 1.3.3 Diagnostics Laboratories
      • 1.3.4 Specialty Clinics
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Global Growth Trends

    • 2.1 Global Fecal Pancreatic Elastase Testing Market Perspective (2017-2028)
    • 2.2 Fecal Pancreatic Elastase Testing Growth Trends by Region
      • 2.2.1 Fecal Pancreatic Elastase Testing Market Size by Region: 2017 VS 2021 VS 2028
      • 2.2.2 Fecal Pancreatic Elastase Testing Historic Market Size by Region (2017-2022)
      • 2.2.3 Fecal Pancreatic Elastase Testing Forecasted Market Size by Region (2023-2028)
    • 2.3 Fecal Pancreatic Elastase Testing Market Dynamics
      • 2.3.1 Fecal Pancreatic Elastase Testing Industry Trends
      • 2.3.2 Fecal Pancreatic Elastase Testing Market Drivers
      • 2.3.3 Fecal Pancreatic Elastase Testing Market Challenges
      • 2.3.4 Fecal Pancreatic Elastase Testing Market Restraints

    3 Competition Landscape by Key Players

    • 3.1 Global Top Fecal Pancreatic Elastase Testing Players by Revenue
      • 3.1.1 Global Top Fecal Pancreatic Elastase Testing Players by Revenue (2017-2022)
      • 3.1.2 Global Fecal Pancreatic Elastase Testing Revenue Market Share by Players (2017-2022)
    • 3.2 Global Fecal Pancreatic Elastase Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.3 Players Covered: Ranking by Fecal Pancreatic Elastase Testing Revenue
    • 3.4 Global Fecal Pancreatic Elastase Testing Market Concentration Ratio
      • 3.4.1 Global Fecal Pancreatic Elastase Testing Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Top 10 and Top 5 Companies by Fecal Pancreatic Elastase Testing Revenue in 2021
    • 3.5 Fecal Pancreatic Elastase Testing Key Players Head office and Area Served
    • 3.6 Key Players Fecal Pancreatic Elastase Testing Product Solution and Service
    • 3.7 Date of Enter into Fecal Pancreatic Elastase Testing Market
    • 3.8 Mergers & Acquisitions, Expansion Plans

    4 Fecal Pancreatic Elastase Testing Breakdown Data by Type

    • 4.1 Global Fecal Pancreatic Elastase Testing Historic Market Size by Type (2017-2022)
    • 4.2 Global Fecal Pancreatic Elastase Testing Forecasted Market Size by Type (2023-2028)

    5 Fecal Pancreatic Elastase Testing Breakdown Data by Application

    • 5.1 Global Fecal Pancreatic Elastase Testing Historic Market Size by Application (2017-2022)
    • 5.2 Global Fecal Pancreatic Elastase Testing Forecasted Market Size by Application (2023-2028)

    6 North America

    • 6.1 North America Fecal Pancreatic Elastase Testing Market Size (2017-2028)
    • 6.2 North America Fecal Pancreatic Elastase Testing Market Size by Type
      • 6.2.1 North America Fecal Pancreatic Elastase Testing Market Size by Type (2017-2022)
      • 6.2.2 North America Fecal Pancreatic Elastase Testing Market Size by Type (2023-2028)
      • 6.2.3 North America Fecal Pancreatic Elastase Testing Market Share by Type (2017-2028)
    • 6.3 North America Fecal Pancreatic Elastase Testing Market Size by Application
      • 6.3.1 North America Fecal Pancreatic Elastase Testing Market Size by Application (2017-2022)
      • 6.3.2 North America Fecal Pancreatic Elastase Testing Market Size by Application (2023-2028)
      • 6.3.3 North America Fecal Pancreatic Elastase Testing Market Share by Application (2017-2028)
    • 6.4 North America Fecal Pancreatic Elastase Testing Market Size by Country
      • 6.4.1 North America Fecal Pancreatic Elastase Testing Market Size by Country (2017-2022)
      • 6.4.2 North America Fecal Pancreatic Elastase Testing Market Size by Country (2023-2028)
      • 6.4.3 United States
      • 6.4.4 Canada

    7 Europe

    • 7.1 Europe Fecal Pancreatic Elastase Testing Market Size (2017-2028)
    • 7.2 Europe Fecal Pancreatic Elastase Testing Market Size by Type
      • 7.2.1 Europe Fecal Pancreatic Elastase Testing Market Size by Type (2017-2022)
      • 7.2.2 Europe Fecal Pancreatic Elastase Testing Market Size by Type (2023-2028)
      • 7.2.3 Europe Fecal Pancreatic Elastase Testing Market Share by Type (2017-2028)
    • 7.3 Europe Fecal Pancreatic Elastase Testing Market Size by Application
      • 7.3.1 Europe Fecal Pancreatic Elastase Testing Market Size by Application (2017-2022)
      • 7.3.2 Europe Fecal Pancreatic Elastase Testing Market Size by Application (2023-2028)
      • 7.3.3 Europe Fecal Pancreatic Elastase Testing Market Share by Application (2017-2028)
    • 7.4 Europe Fecal Pancreatic Elastase Testing Market Size by Country
      • 7.4.1 Europe Fecal Pancreatic Elastase Testing Market Size by Country (2017-2022)
      • 7.4.2 Europe Fecal Pancreatic Elastase Testing Market Size by Country (2023-2028)
      • 7.4.3 Germany
      • 7.4.4 France
      • 7.4.5 U.K.
      • 7.4.6 Italy
      • 7.4.7 Russia
      • 7.4.8 Nordic Countries

    8 Asia-Pacific

    • 8.1 Asia-Pacific Fecal Pancreatic Elastase Testing Market Size (2017-2028)
    • 8.2 Asia-Pacific Fecal Pancreatic Elastase Testing Market Size by Type
      • 8.2.1 Asia-Pacific Fecal Pancreatic Elastase Testing Market Size by Type (2017-2022)
      • 8.2.2 Asia-Pacific Fecal Pancreatic Elastase Testing Market Size by Type (2023-2028)
      • 8.2.3 Asia-Pacific Fecal Pancreatic Elastase Testing Market Share by Type (2017-2028)
    • 8.3 Asia-Pacific Fecal Pancreatic Elastase Testing Market Size by Application
      • 8.3.1 Asia-Pacific Fecal Pancreatic Elastase Testing Market Size by Application (2017-2022)
      • 8.3.2 Asia-Pacific Fecal Pancreatic Elastase Testing Market Size by Application (2023-2028)
      • 8.3.3 Asia-Pacific Fecal Pancreatic Elastase Testing Market Share by Application (2017-2028)
    • 8.4 Asia-Pacific Fecal Pancreatic Elastase Testing Market Size by Region
      • 8.4.1 Asia-Pacific Fecal Pancreatic Elastase Testing Market Size by Region (2017-2022)
      • 8.4.2 Asia-Pacific Fecal Pancreatic Elastase Testing Market Size by Region (2023-2028)
      • 8.4.3 China
      • 8.4.4 Japan
      • 8.4.5 South Korea
      • 8.4.6 Southeast Asia
      • 8.4.7 India
      • 8.4.8 Australia

    9 Latin America

    • 9.1 Latin America Fecal Pancreatic Elastase Testing Market Size (2017-2028)
    • 9.2 Latin America Fecal Pancreatic Elastase Testing Market Size by Type
      • 9.2.1 Latin America Fecal Pancreatic Elastase Testing Market Size by Type (2017-2022)
      • 9.2.2 Latin America Fecal Pancreatic Elastase Testing Market Size by Type (2023-2028)
      • 9.2.3 Latin America Fecal Pancreatic Elastase Testing Market Share by Type (2017-2028)
    • 9.3 Latin America Fecal Pancreatic Elastase Testing Market Size by Application
      • 9.3.1 Latin America Fecal Pancreatic Elastase Testing Market Size by Application (2017-2022)
      • 9.3.2 Latin America Fecal Pancreatic Elastase Testing Market Size by Application (2023-2028)
      • 9.3.3 Latin America Fecal Pancreatic Elastase Testing Market Share by Application (2017-2028)
    • 9.4 Latin America Fecal Pancreatic Elastase Testing Market Size by Country
      • 9.4.1 Latin America Fecal Pancreatic Elastase Testing Market Size by Country (2017-2022)
      • 9.4.2 Latin America Fecal Pancreatic Elastase Testing Market Size by Country (2023-2028)
      • 9.4.3 Mexico
      • 9.4.4 Brazil

    10 Middle East & Africa

    • 10.1 Middle East & Africa Fecal Pancreatic Elastase Testing Market Size (2017-2028)
    • 10.2 Middle East & Africa Fecal Pancreatic Elastase Testing Market Size by Type
      • 10.2.1 Middle East & Africa Fecal Pancreatic Elastase Testing Market Size by Type (2017-2022)
      • 10.2.2 Middle East & Africa Fecal Pancreatic Elastase Testing Market Size by Type (2023-2028)
      • 10.2.3 Middle East & Africa Fecal Pancreatic Elastase Testing Market Share by Type (2017-2028)
    • 10.3 Middle East & Africa Fecal Pancreatic Elastase Testing Market Size by Application
      • 10.3.1 Middle East & Africa Fecal Pancreatic Elastase Testing Market Size by Application (2017-2022)
      • 10.3.2 Middle East & Africa Fecal Pancreatic Elastase Testing Market Size by Application (2023-2028)
      • 10.3.3 Middle East & Africa Fecal Pancreatic Elastase Testing Market Share by Application (2017-2028)
    • 10.4 Middle East & Africa Fecal Pancreatic Elastase Testing Market Size by Country
      • 10.4.1 Middle East & Africa Fecal Pancreatic Elastase Testing Market Size by Country (2017-2022)
      • 10.4.2 Middle East & Africa Fecal Pancreatic Elastase Testing Market Size by Country (2023-2028)
      • 10.4.3 Turkey
      • 10.4.4 Saudi Arabia
      • 10.4.5 UAE

    11 Key Players Profiles

    • 11.1 Labcorp
      • 11.1.1 Labcorp Company Details
      • 11.1.2 Labcorp Business Overview
      • 11.1.3 Labcorp Fecal Pancreatic Elastase Testing Introduction
      • 11.1.4 Labcorp Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
      • 11.1.5 Labcorp Recent Developments
    • 11.2 DiaSorin
      • 11.2.1 DiaSorin Company Details
      • 11.2.2 DiaSorin Business Overview
      • 11.2.3 DiaSorin Fecal Pancreatic Elastase Testing Introduction
      • 11.2.4 DiaSorin Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
      • 11.2.5 DiaSorin Recent Developments
    • 11.3 ScheBo Biotech AG
      • 11.3.1 ScheBo Biotech AG Company Details
      • 11.3.2 ScheBo Biotech AG Business Overview
      • 11.3.3 ScheBo Biotech AG Fecal Pancreatic Elastase Testing Introduction
      • 11.3.4 ScheBo Biotech AG Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
      • 11.3.5 ScheBo Biotech AG Recent Developments
    • 11.4 Immundiagnostik AG
      • 11.4.1 Immundiagnostik AG Company Details
      • 11.4.2 Immundiagnostik AG Business Overview
      • 11.4.3 Immundiagnostik AG Fecal Pancreatic Elastase Testing Introduction
      • 11.4.4 Immundiagnostik AG Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
      • 11.4.5 Immundiagnostik AG Recent Developments
    • 11.5 Invivo Healthcare
      • 11.5.1 Invivo Healthcare Company Details
      • 11.5.2 Invivo Healthcare Business Overview
      • 11.5.3 Invivo Healthcare Fecal Pancreatic Elastase Testing Introduction
      • 11.5.4 Invivo Healthcare Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
      • 11.5.5 Invivo Healthcare Recent Developments
    • 11.6 DRG Instruments GMBH
      • 11.6.1 DRG Instruments GMBH Company Details
      • 11.6.2 DRG Instruments GMBH Business Overview
      • 11.6.3 DRG Instruments GMBH Fecal Pancreatic Elastase Testing Introduction
      • 11.6.4 DRG Instruments GMBH Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
      • 11.6.5 DRG Instruments GMBH Recent Developments
    • 11.7 Verisana Laboratories
      • 11.7.1 Verisana Laboratories Company Details
      • 11.7.2 Verisana Laboratories Business Overview
      • 11.7.3 Verisana Laboratories Fecal Pancreatic Elastase Testing Introduction
      • 11.7.4 Verisana Laboratories Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
      • 11.7.5 Verisana Laboratories Recent Developments
    • 11.8 BÜHLMANN Laboratories AG
      • 11.8.1 BÜHLMANN Laboratories AG Company Details
      • 11.8.2 BÜHLMANN Laboratories AG Business Overview
      • 11.8.3 BÜHLMANN Laboratories AG Fecal Pancreatic Elastase Testing Introduction
      • 11.8.4 BÜHLMANN Laboratories AG Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
      • 11.8.5 BÜHLMANN Laboratories AG Recent Developments
    • 11.9 CerTest Biotec
      • 11.9.1 CerTest Biotec Company Details
      • 11.9.2 CerTest Biotec Business Overview
      • 11.9.3 CerTest Biotec Fecal Pancreatic Elastase Testing Introduction
      • 11.9.4 CerTest Biotec Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
      • 11.9.5 CerTest Biotec Recent Developments
    • 11.10 R-Biopharm AG
      • 11.10.1 R-Biopharm AG Company Details
      • 11.10.2 R-Biopharm AG Business Overview
      • 11.10.3 R-Biopharm AG Fecal Pancreatic Elastase Testing Introduction
      • 11.10.4 R-Biopharm AG Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
      • 11.10.5 R-Biopharm AG Recent Developments
    • 11.11 Vitassay Healthcare
      • 11.11.1 Vitassay Healthcare Company Details
      • 11.11.2 Vitassay Healthcare Business Overview
      • 11.11.3 Vitassay Healthcare Fecal Pancreatic Elastase Testing Introduction
      • 11.11.4 Vitassay Healthcare Revenue in Fecal Pancreatic Elastase Testing Business (2017-2022)
      • 11.11.5 Vitassay Healthcare Recent Developments

    12 Analyst's Viewpoints/Conclusions

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
        • 13.1.2 Data Source
      • 13.2 Author Details

      Summary:
      Get latest Market Research Reports on Fecal Pancreatic Elastase Testing. Industry analysis & Market Report on Fecal Pancreatic Elastase Testing is a syndicated market report, published as Global Fecal Pancreatic Elastase Testing Market Insights, Forecast to 2028. It is complete Research Study and Industry Analysis of Fecal Pancreatic Elastase Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,350.00
      $8,700.00
      3,497.40
      6,994.80
      4,067.25
      8,134.50
      672,988.50
      1,345,977.00
      362,485.50
      724,971.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report